Brief: Neuroone Reports First Quarter Fiscal Year 2023 Financial Results
Feb 14 (Reuters) - Neuroone Medical Technologies Corp
NMTC.O :
* NEUROONE® REPORTS FIRST QUARTER FISCAL YEAR 2023 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* NEUROONE MEDICAL TECHNOLOGIES CORP - QTRLY LOSS PER SHARE
$0.11
Source text for Eikon: ID:nPn25lmz8a
Further company coverage: NMTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroone Medical Technologies
See all newsBrief: Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing
NeuroOne Medical Technologies Corp reports results for the quarter ended June 30 - Earnings Summary
NeuroOne Medical Technologies Corp expected to post a loss of 22 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings
NASDAQ RESUMED AT 09:00 AM